骨折后管理:我们需要教育患者而非医生吗?PREVOST随机对照试验
这项多中心随机对照试验纳入436名50至85岁因腕部或肱骨低能量骨折就诊于法国医院的女性,评估以患者为中心、由专职个案管理员实施的骨折后骨质疏松管理项目(PREVOST)的效果。结果显示,与常规管理相比,干预组6个月时启动骨折后管理(BMD检查和/或抗骨质疏松治疗处方)的比例显著提高(53% vs 33%,adjOR 2.35,95%CI 1.58-3.50,p<0.001)。
要点
- 干预组6个月启动骨折后管理比例53%,常规组33%(adjOR 2.35,95%CI 1.58-3.50,p<0.001)。
- 干预组BMD检查执行率41% vs 常规组25%(adjOR 2.12,95%CI 1.40-3.20,p<0.001)。
- 低骨量且按法国指南需治疗女性中仅46%获得处方。
核心结论
- 以患者为中心、由专职个案管理员实施的护理项目可显著改善骨折后BMD检查。
研究设计与样本
- 多中心随机对照试验,纳入436名50至85岁因腕部或肱骨低能量骨折就诊于法国医院的女性。
- 随机化按年龄、医院科室和骨折部位分层。
- 干预由经过培训的个案管理员实施,仅与患者互动,反复提供口头和书面信息并促使其就诊初级保健医生;对照组接受常规管理。
主要发现
- 6个月时干预组53%启动骨折后管理,常规组33%(adjOR 2.35,95%CI 1.58-3.50,p<0.001)。
- 腕部骨折后骨折后管理比肱骨骨折更常见(adjOR 1.93,95%CI 1.14-3.30,p=0.015),且随年龄增长而下降(每增加10岁adjOR 0.76,95%CI 0.61-0.96,p=0.02)。
- 干预组BMD处方率50% vs 常规组33%(adjOR 2.10,95%CI 1.41-3.11,p<0.001),BMD执行率41% vs 常规组25%(adjOR 2.12,95%CI 1.40-3.20,p<0.001)。
- 已执行BMD可增加治疗处方;但按法国指南需治疗的低骨量女性中仅46%获得处方。
关键数值与推荐
- 主要结局为6个月时启动适当的骨折后管理,定义为BMD和/或抗骨质疏松治疗处方。
- 干预组53% vs 常规组33%启动骨折后管理(adjOR 2.35,95%CI 1.58-3.50,p<0.001)。
- 干预组BMD处方率50% vs 常规组33%(adjOR 2.10,95%CI 1.41-3.11,p<0.001)。
- 干预组BMD执行率41% vs 常规组25%(adjOR 2.12,95%CI 1.40-3.20,p<0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: We conducted a multicenter, randomized controlled trial to evaluate the impact of a population-based patient-centered post-fracture care program with a dedicated case manager, PREVention of OSTeoporosis (PREVOST), on appropriate post-fracture osteoporosis management. We showed that, compared to usual care, BMD investigation post-fracture was significantly improved (+20%) by our intervention program. INTRODUCTION: Our study aims to evaluate the impact of a population-based patient-centered post-fracture care program, PREVOST, on appropriate post-fracture care. METHODS: Multicenter, randomized controlled trial enrolling 436 women aged 50 to 85 years and attending a French hospital, for a low-energy fracture of the wrist or humerus. Randomization was stratified by age, hospital department, and site of fracture. The intervention was performed by a trained case manager who interacted only with the patients, with repeated oral and written information about fragility fractures and osteoporosis management, and prompting them to visit their primary care physicians. Control group received usual care. The primary outcome was the initiation of an appropriate post-fracture care defined by Bone Mineral Density (BMD) and/or anti-osteoporotic treatment prescription at 6 months. RESULTS: At 6 months, 53% of women in intervention group initiated a post-fracture care versus 33% for usual care (adjOR 2.35, 95%CI [1.58-3.50], p < 0.001). Post-fracture care was more frequent after wrist than humerus fracture (adjOR 1.93, 95%CI [1.14-3.30], p = 0.015) and decreased with age (adjOR for 10 years increase 0.76, 95%CI [0.61-0.96], p = 0.02). The intervention resulted in BMD prescription in 50% of patients (adjOR 2.10, 95%CI [1.41-3.11], p < 0.001) and in BMD performance in 41% of patients (adjOR 2.12, 95%CI [1.40-3.20], p < 0.001) versus 33 and 25% for usual care, respectively. Having performed a BMD increased treatment prescription; however, only 46% of women with a low BMD requiring a treatment according to the French guidelines received a prescription. CONCLUSION: A patient-centered care program with a dedicated case manager can significantly improve post-fracture BMD investigation.
引用
- Merle B, Chapurlat R, Vignot E, et al. Post-fracture care: do we need to educate patients rather than doctors? The PREVOST randomized controlled trial. Osteoporos Int. 2017. PMID: 28246884. doi:10.1007/s00198-017-3953-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。